The present and future of haploidentical hematopoietic stem cell transplantation in China
10.3760/cma.j.cn121090-20240215-00061
- VernacularTitle:我国单倍体造血干细胞移植的现状和未来
- Author:
Xiaodong MO
1
;
Xiaojun HUANG
Author Information
1. 北京大学人民医院，北京大学血液病研究所，国家血液系统疾病临床医学研究中心，造血干细胞移植治疗血液病北京市重点实验室，北京 100044
- From:
Chinese Journal of Hematology
2024;45(7):625-628
- CountryChina
- Language:Chinese
-
Abstract:
The lack of donors is the biggest obstacle to the widespread use of hematopoietic stem cell transplantation. The establishment and improvement of new transplantation schemes have made haploid hematopoietic stem cell transplantation a clinical routine, benefiting a large number of patients with hematological diseases. Haploid donors have become the most important source of donors for allogeneic hematopoietic stem cell transplantation in China. This article focuses on the current situation and future development trends of haploid hematopoietic stem cell transplantation in China, in order to increase the understanding of clinical doctors on haploid hematopoietic stem cell transplantation.
